Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (231-240 of 576) with videos related to

Pageof 58
Sort By:
Clinical Lung Cancer|December 10, 2003
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancerEverett E Vokes, Chaiyut Charoentum, Gary S Gordon, et al.
Advances in Radiation Oncology|December 6, 2017
Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerBenjamin H Lok, Jennifer Ma, Amanda Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2011
Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine featuresCharles M Rudin, John T Poirier, Neil N Senzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancerC M Rudin, G A Otterson, A M Mauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2019
Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancerNarek Shaverdian, Michael D Offin, Andreas Rimner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2011
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancerMaria Q Baggstrom, Yingwei Qi, Marianna Koczywas, et al.
Pediatric Blood & Cancer|October 14, 2014
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology GroupMichael J Burke, Charlotte Ahern, Brenda J Weigel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians GuidelineCharles M Rudin, Nofisat Ismaila, Christine L Hann, et al.
Cancer Discovery|December 15, 2020
A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung CancerPortia L Thomas, Chioma J Madubata, Melinda C Aldrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2009
Lung cancer in never smokers: molecular profiles and therapeutic implicationsCharles M Rudin, Erika Avila-Tang, Curtis C Harris, et al.
Pageof 58

Showing results (231-240 of 576) with videos related to

Sort By:
Pageof 58
Clinical Lung Cancer|December 10, 2003
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancerEverett E Vokes, Chaiyut Charoentum, Gary S Gordon, et al.
Advances in Radiation Oncology|December 6, 2017
Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerBenjamin H Lok, Jennifer Ma, Amanda Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2011
Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine featuresCharles M Rudin, John T Poirier, Neil N Senzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancerC M Rudin, G A Otterson, A M Mauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 2, 2019
Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancerNarek Shaverdian, Michael D Offin, Andreas Rimner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2011
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancerMaria Q Baggstrom, Yingwei Qi, Marianna Koczywas, et al.
Pediatric Blood & Cancer|October 14, 2014
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology GroupMichael J Burke, Charlotte Ahern, Brenda J Weigel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians GuidelineCharles M Rudin, Nofisat Ismaila, Christine L Hann, et al.
Cancer Discovery|December 15, 2020
A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung CancerPortia L Thomas, Chioma J Madubata, Melinda C Aldrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2009
Lung cancer in never smokers: molecular profiles and therapeutic implicationsCharles M Rudin, Erika Avila-Tang, Curtis C Harris, et al.
Pageof 58